Evidence map›Paper›PMID 37959659›Full record

ArticleMolecules (Basel, Switzerland)2023

Analysis of Skin Regeneration and Barrier-Improvement Efficacy of Polydeoxyribonucleotide Isolated from Panax Ginseng (C.A. Mey.) Adventitious Root.

Kwang-Soo Lee, Soyeon Lee, Hyesoo Wang, Geonhee Lee, Seolyeong Kim, Yang-Hwan Ryu, Nicole Hyesoo Chang, Yong-Won Kang

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Journal of functional biomaterials · 2026
    Article
  6. Protective Effect of Peony (Molecules (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Anti-Inflammatory Activity of Compounds Isolated fromInternational journal of molecular sciences · 2025
    Article
  12. Review
  13. Review of Preclinical and Clinical Studies Supporting the Role of Polydeoxyribonucleotide in the Treatment of Tendon Disorders.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. The Effect of Polynucleotide-Hyaluronic Acid Hydrogel in the Recovery After Mechanical Skin Barrier Disruption.Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Kwang-Soo LeeBio Convergence Material Division, Biosolution Co., Ltd., Seoul 06746, Republic of Korea.
Soyeon LeeBio Convergence Material Division, Biosolution Co., Ltd., Seoul 06746, Republic of Korea.
Hyesoo WangBio Convergence Material Division, Biosolution Co., Ltd., Seoul 06746, Republic of Korea.
Geonhee LeeNon-Clinical R&D Center, Biosolution Co., Ltd., Seoul 06746, Republic of Korea.
Seolyeong KimNon-Clinical R&D Center, Biosolution Co., Ltd., Seoul 06746, Republic of Korea.
Yang-Hwan RyuBio Convergence Material Division, Biosolution Co., Ltd., Seoul 06746, Republic of Korea.
Nicole Hyesoo ChangDepartment of Medicine, McMaster University, Hamilton, ON L8S 4L8, Canada.
Yong-Won KangBio Convergence Material Division, Biosolution Co., Ltd., Seoul 06746, Republic of Korea.
Biosolution (South Korea) · KRKorea University · KRMcMaster University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polydeoxyribonucleotide (PDRN) has the ability to regenerate skin cells and improve the skin barrier and wound healing. This study investigated the possibility of replacing animal-derived PDRN with plant-derived PDRN. To test this, the adventitious roots of Korean ginseng (Panax ginseng C.A. Meyer), which is commonly used to treat various diseases, were suspension-cultivated through tissue culture; subsequently, PDRN was purified using microfluidization, an ultra-high-pressure physical grinding method. The results showed that purified Panax PDRN was effective in healing skin wounds and enhancing the skin barrier. Panax PDRN promoted the proliferation of keratinocytes and fibroblasts by increasing the expression of fibronectin, filaggrin, Ki-67, Bcl-2, inhibin beta A, and Cyclin D1. It also acted as an agonist of the adenosine A2A receptor and induced the phosphorylation of focal adhesion kinase, adenosine triphosphate-dependent tyrosine kinase, and mitogen-activated protein kinase. This activated signal transduction, thereby regenerating skin cells and strengthening the barrier. These results were not only observed in skin cells but also in an artificial skin model (KeraSkin

Indexed as

PanaxPolydeoxyribonucleotidesAnimalsKeratinocytesSkinWound HealingPolydeoxyribonucleotidesPanax ginsengplant-derived polydeoxyribonucleotidepolydeoxyribonucleotideskin barrierskin regenerationwound healing

Identifiers

PMID37959659
PMCPMC10649580
OpenAlexW4387903089

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.